After finishing at $109.47 in the prior trading day, Cardinal Health, Inc. (NYSE: CAH) closed at $108.07, down -1.28%. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 1543361 shares were traded.
Ratios:
Our goal is to gain a better understanding of CAH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.68. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.98.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $125.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $117.Barclays initiated its Overweight rating on January 03, 2024, with a $117 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’23 when WEITZMAN DEBORAH sold 36,642 shares for $106.31 per share. The transaction valued at 3,895,411 led to the insider holds 35,202 shares of the business.
WEITZMAN DEBORAH sold 6,712 shares of CAH for $602,805 on Aug 28 ’23. The CEO, Pharmaceutical Segment now owns 44,202 shares after completing the transaction at $89.81 per share. On Aug 18 ’23, another insider, Scherer Mary C., who serves as the Chief Accounting Officer of the company, sold 20,695 shares for $86.27 each. As a result, the insider received 1,785,358 and left with 10,649 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 26.29B and an Enterprise Value of 26.42B. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 42.54, and their Forward P/E ratio for the next fiscal year is 13.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.12. Its current Enterprise Value per Revenue stands at 0.12 whereas that against EBITDA is 13.96.
Stock Price History:
Over the past 52 weeks, CAH has reached a high of $116.04, while it has fallen to a 52-week low of $77.56. The 50-Day Moving Average of the stock is 109.22, while the 200-Day Moving Average is calculated to be 99.29.
Shares Statistics:
The stock has traded on average 2.36M shares per day over the past 3-months and 1.49M shares per day over the last 10 days, according to various share statistics. A total of 251.00M shares are outstanding, with a floating share count of 241.78M. Insiders hold about 0.60% of the company’s shares, while institutions hold 89.06% stake in the company. Shares short for CAH as of Mar 28, 2024 were 9.04M with a Short Ratio of 3.65, compared to 10.65M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.72% and a Short% of Float of 4.96%.
Dividends & Splits
In the trailing 12 months, CAH’s forward annual dividend rate was 2.00, compared to 2.00 this year. Against a Trailing Annual Dividend Yield of 1.83%, it implies a Forward Annual Dividend Yield of 1.85%. The stock’s 5-year Average Dividend Yield is 3.28. The current Payout Ratio is 199.53% for CAH, which recently paid a dividend on Apr 15, 2024 with an ex-dividend date of Mar 28, 2024. Stock splits for the company last occurred on Apr 23, 2001 when the company split stock in a 3:2 ratio.
Earnings Estimates
Its stock is currently analyzed by 13 different market analysts. On average, analysts expect EPS of $1.96 for the current quarter, with a high estimate of $2.02 and a low estimate of $1.9, while EPS last year was $1.74. The consensus estimate for the next quarter is $1.79, with high estimates of $1.86 and low estimates of $1.7.
Analysts are recommending an EPS of between $7.35 and $7.14 for the fiscal current year, implying an average EPS of $7.3. EPS for the following year is $8.01, with 18 analysts recommending between $8.43 and $7.65.
Revenue Estimates
A total of 15 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $229B, while the lowest revenue estimate was $224.71B, resulting in an average revenue estimate of $226.95B. In the same quarter a year ago, actual revenue was $205.01B, up 10.70% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $246.18B in the next fiscal year. The high estimate is $251B and the low estimate is $240.62B. The average revenue growth estimate for next year is up 8.50% from the average revenue estimate for this year.
